Solara Active Pharma Sciences Ltd Share Price

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

NSE: SOLARA Small Cap ISIN: INE624Z01016

As on 22 January 2025 at 18:17 IST

₹659.10

-14.95

(-2.22%)

Sell Buy

Over 1 Month

2.23%

Over 6 Months

17.20%

Over 1 Year

90.02%

Over 3 Years

-28.24%

Solara Active Pharma Sciences Ltd Summary

Close ₹ 659.10

Open ₹ 667.90

High ₹ 677

Low ₹ 639

Volume 63,077

Net Turnover (in ₹) ₹ 5,78,64,773.40

52Wk High ₹ 882.80

52Wk Low ₹ 322.53

52Wk High / Low

322.53

882.80

Solara Active Pharma Sciences Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 2,906.65

EPS (TTM) -

Book Value (BV) 301.39

Div. Yield -

P/E (TTM) -4.54

Price/Book Value 2.24

Delivery % 50.02 %

Face Value 10

Key Ratios

PE Ratio -

PB Ratio 1.43

EV to Sales 1.82

PEG Ratio -

ROA -28.30

ROE -

Debt-Equity 0.83

Net Profit Margin -31.66

Operating Profit Margin -6.99

Solara Active Pharma Sciences Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	1,294.29	1,466.36	1,288.36	1,645.65	1,349.27
Total Expenses	1,592.54	1,511.18	1,375.97	1,424.15	1,234.36
Profit Before Tax	-488.42	-44.82	-91.10	221.50	114.91
Profit After Tax	-566.96	-22.25	-58.29	221.35	114.52
Operating Profit after Depreciation	-193.14	45.24	-12.33	305.98	192.80

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	1,265.50	1,340.02	1,331.80	1,356.29	1,368.46
Total Non Current Assets	1,550.21	1,711.74	1,705.68	1,555.95	1,481.51
Total Current Assets	800.75	1,187.54	1,239.28	1,057.63	671.99
TOTAL ASSETS	2,350.96	2,899.28	2,944.96	2,613.58	2,153.50
Total Shareholder's Fund	933.91	1,500.21	1,524.87	1,588.53	1,085.94

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	108.87	156.25	-242.03	155.46	242.15
Net Cash used in Investing Activities	-3.51	-81.14	-242.85	-106.30	-358.81
Net Cash used in Financing Activities	-105.65	-112.76	333.57	92.49	96.98

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	1,294.29	1,465.95	1,287.10	1,645.29	1,349.26
Total Expenses	1,592.98	1,510.73	1,375.27	1,424.33	1,236.77
Profit Before Tax	-488.33	-44.78	-91.66	220.96	112.49
Profit After Tax	-566.87	-22.21	-58.56	220.96	112.49
Operating Profit after Depreciation	-192.72	45.28	-12.90	305.43	190.37

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	1,258.70	1,333.22	1,325	1,349.49	1,361.62
Total Non Current Assets	1,555.95	1,704.08	1,697.57	1,552.18	1,476.26
Total Current Assets	790.65	1,190.87	1,239.87	1,057.99	675.35
TOTAL ASSETS	2,346.60	2,894.95	2,937.44	2,610.17	2,151.61
Total Shareholder's Fund	937.42	1,503.13	1,527.05	1,592.79	1,090.79

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	110.95	156.17	-241.77	154.44	242.02
Net Cash used in Investing Activities	-4.66	-81.13	-243.08	-105.25	-358.81
Net Cash used in Financing Activities	-106.52	-112.76	333.59	92.50	97.01

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	346.95	363.49	299.43	248.73	425.24
Total Expenses	285.64	321.57	289.67	410.42	387.61
Profit Before Tax	8.01	-13.46	-166.66	-275.34	-17.06
Profit After Tax	8.01	-13.46	-255.45	-275.34	-17.06
Operating Profit after Depreciation	61.63	42.48	11.46	-161.24	38.81

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	346.95	363.49	299.43	248.73	425.24
Total Expenses	285.63	321.25	289.63	410.40	387.57
Profit Before Tax	8.02	-12.32	-167.61	-275.33	-15.26
Profit After Tax	8.02	-12.32	-256.40	-275.33	-15.26
Operating Profit after Depreciation	61.64	43.62	11.43	-161.23	38.90

Solara Active Pharma Sciences Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 656.43

S2 638.82

S3 607.53

Pivot 687.72

R1 705.33

R2 736.62

R3 754.23

Moving Average

20 SMA 676.38

50 SMA 732.78

100 SMA 749.40

200 SMA 635.98

Solara Active Pharma Sciences Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

No available data

AGM Date: 25 Aug 2022

We wish to inform about Newspaper Advertisements for 5th Annual General Meeting of the Company to be held through Video Conferencing (VC)/Other Audio-Visual Means (OAVM) on August 25, 2022. We wish to inform you that the Register of Members and Share transfer books shall remain closed from August 18, 2022, to August 25, 2022 (both days inclusive) for the purpose of 5th Annual General Meeting of the company for the Financial Year 2021-22. With reference to the above subject, please find enclosed herewith the newspaper advertisement published in Business Standard (English Edition) and Pratahkal (Marathi Edition) on August 2, 2022, regarding notice of 5th Annual General Meeting and e-Voting information. (As Per BSE Announcement Dated on 02.08.2022) This is in continuation to our letter dated August 4, 2022, informing about the cessation of directorship of Mr. Kartheek Raju (DIN: 02921819) as a Director of the Company pursuant to his resignation on August 3, 2022. Consequent to above, Resolution No. 3 of the Notice of Fifth Annual General Meeting scheduled to be held on August 25, 2022, to resolved that 'To appoint a director in place of Mr. Kartheek Raju Chintalapati (holding DIN 02921819) who retires by rotation and being eligible offers himself for reappointment as Non-Executive Director of the Company' has become redundant and stands withdrawn. (As Per BSE Announcement dated on 10.08.2022) We wish to inform you that the Fifth Annual General Meeting ('AGM') of the Company was held on Thursday, August 25, 2022, through Video Conferencing. Please find attached the summary of proceedings of the AGM as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (As Per BSE Announcement Dated on 25.08.2022) Submission of Voting Results of the 5th Annual General Meet ing Ref: Reg. 44 of SEBI (Listing Obligat ions and Disclosure Requirements) Regulations, 2015. (As Per BSE Announcement Dated on 27.08.2022) Solara Active Pharma Sciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here (As Per BSE Announcement Dated 29.08.2022)

AGM Date: 15 Sep 2023

AGM 15/09/2023 Proceedings of the 6th Annual General Meeting (AGM) of the Company. (As Per BSE Announcement Dated on 15/09/2023)

AGM Date: 20 Sep 2024

AGM 20/09/2024 Newspaper advertisement before dispatch of notice of the Seventh Annual General Meeting (As Per BSE Announcement Dated on 26.08.2024) Solara Active Pharma Sciences Limited has informed the Exchange regarding Proceedings of Seventh Annual General Meeting held on Friday, September 20, 2024 at Bangalore, commenced at 10:00 A.M. and concluded at 11:10 A.M. (As per BSE Announcement Dated on 20/09/2024)

Solara Active Pharma Sciences Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Solara Active Pharma Sciences Ltd	₹674.35	₹2,431.32
Sun Pharmaceuticals Industries Ltd	₹1,761.80	₹4,22,714.84
Divis Laboratories Ltd	₹5,818.40	₹1,54,460.24
Cipla Ltd	₹1,427.30	₹1,15,270.75
Dr Reddys Laboratories Ltd	₹1,288.45	₹1,07,511.36
Torrent Pharmaceuticals Ltd	₹3,157.60	₹1,06,862.73

Solara Active Pharma Sciences Ltd News

Solara Active Pharma Sciences announces board meeting date

On 24 January 2025

16 Jan 2025, 04:10 pm

Solara Active Pharma Sciences Ltd Surges 2.77%

Solara Active Pharma Sciences Ltd has lost 12.6% over last one month compared to 1.18% gain in BSE Healthcare index and 4.52% drop in the SENSEX

07 Jan 2025, 09:30 am

Solara Active Pharma Sciences allots 49,000 equity shares under ESOP

21 Oct 2024, 02:03 pm

Solara Active Pharma Sciences to declare Quarterly Result

On 21 October 2024

15 Oct 2024, 10:21 am

Solara Active Pharma Sciences schedules AGM

On 20 September 2024

30 Aug 2024, 04:36 pm

Solara Active Pharma Sciences Ltd Stock Analysis

Annual revenue for Solara Active Pharma Sciences Ltd decreased by 11.71% to ₹1,294.29 crore in FY 2024 from ₹1,465.95 crore in FY 2023.
Annual Net Profit for Solara Active Pharma Sciences Ltd increased by 2452.32% to ₹-566.87 crore in FY 2024 from ₹-22.21 crore in FY 2023.
Promoter Shareholding in Solara Active Pharma Sciences Ltd remains unchanged by 0.00% in the most recent quarter, from 37.27% in June 2024 to 37.27% in September 2024.
Solara Active Pharma Sciences Ltd delivered a 1-year return of 90.02% compared to the Nifty 50, which provided a return of 8.41% as of the last trading session.
Solara Active Pharma Sciences Ltd share price moved down by 2.22% from its previous close of INR ₹674.05. The latest Solara Active Pharma Sciences Ltd share price is INR ₹659.10.
Solara Active Pharma Sciences Ltd share price today has been at a low of 639 and a high of 677. Over the past 52 weeks, the Solara Active Pharma Sciences Ltd share price has seen a low of 322.53 and a high of 882.80.